Market

Biosimilar Trastuzumab will help in the treatment of Her 2+ metastatic breast cancer

Initiates an important first step towards the creation of a single Pfizer brand in India

Is anticipated to receive market approval in the US on Dec 8

Establishes CMO/ CRO and API manufacturing facility in New Jersey, US

Plans to launch the product in Saudi Arabia early next year

Valued at Rs 6305 crores, with 10 therapies and 12 regions exceeding market growth rate

Organisers CubeX, key speaker Nicholas Hall uncover little known aspects of pharma OTC

4,022 trade visitors attended the event at Bombay Exhibition Centre

Features insights, solutions and tools to better cope with the challenges ahead

Speakers highlight need for clarity on regulations in today’schanging environment. Express Pharma was the exclusive media partner